303
Participants
Start Date
May 16, 2017
Primary Completion Date
August 13, 2018
Study Completion Date
January 9, 2019
Apremilast
Apremilast 30 mg tablets BID from weeks 0 to 32.
Placebo
Placebo tablets twice daily (BID) for 16 weeks; placebo participants were switched to apremilast 30 mg at week 16.
Icahn School of Medicine at Mount Sinai Medical Center, New York
Sadick Research Group, New York
SUNY Downstate Medical Center, Brooklyn
Forest Hills Dermatology Group, Forest Hills
University of Pittsburgh Medical Center, Pittsburgh
Lawrence Green, MD, LLC, Rockville
Virginia Clinical Research Inc, Norfolk
Eastern Virginia Medical School, Norfolk
Wake Forest University Health Sciences, Winston-Salem
MedaPhase INC, Newnan
Dermatologic Surgery Specialists, P.C., Macon
Florida Academic Centers Research and Education, Coral Gables
International Dermatology Research, Miami
Renstar Medical Research, Ocala
DS Research, Louisville
DS Research, Louisville
Wright State Physicians, Fairborn
The Indiana Clinical Trials Center, PC, Plainfield
Medical College of Wisconsin, Milwaukee
Central Dermatology, St Louis
Skin Specialists, PC, Omaha
Dermatology and Advanced Aesthetics, Lake Charles
Northwest Arkansas Clinical Trials Center, PLLC / Hull Dermatology, Rogers
Modern Research Associates PLLC, Dallas
Center for Clinical Studies, Webster
Austin Dermatology Associates, Austin
University of Utah, Salt Lake City
Dermatology Research Associates, Los Angeles
Tien Q. Nguyen MD Inc, Fountain Valley
San Luis Dermatology and Laser Clinic, San Luis Obispo
University of Connecticut, Farmington
Psoriasis Treatment Center of Central New Jersey, East Windsor
Kirk Barber Research, Calgary
Institute for Skin Advancement, Calgary
Chih-Ho Hong Medical, Inc., Surrey
Enverus Medical Research, Surrey
Wiseman Dermatology Research Inc., Winnipeg
Lynderm Research, Markham
North Bay Dermatology Center, North Bay
Skin Center for Dermatology, Peterborough
Centre For Dermatology and Cosmetic Surgery, Richmond Hill
The Toronto Dermatology Centre, Toronto
K. Papp Clinical Research, Waterloo
XLR8 Medical Research, Windsor
Centre de Recherche Dermatologique du Quebec Metropolitain CRDQ, Québec
Lead Sponsor
Amgen
INDUSTRY